Valganciclovir Hydrochloride Tablet
Product Images NDC 72603-750

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 72603-750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mosteller Bsa (Valganciclovir Fig1)

FDA Label Image

Package Label-principal Display Panel (450 mg (60 Tablets Bottle))

This text provides information about Valganciclovir tablets, each containing 450 mg of Valganciclovir hydrochloride USP. The tablets should not be broken or crushed and should be stored at 20° to 25°C. The usual dosage instructions can be found in the package insert. The tablets are to be dispensed in tight containers as per USP INF guidelines. Manufactured for Northstar Rx LLC, the product is a film-coated tablet. It also contains details about the manufacturer, Aurobindo Pharma Limited in India. The expiry date is in 11/2025, and it comes in a pack of 60 tablets. This information is crucial for anyone handling or using Valganciclovir tablets.*

FDA Label Image

Chemical Structure (Valganciclovir Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.